Bellon Christine's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Nov 22, 2023
- Accession no.
- 0000950170-23-065868
- Filed
- Nov 22, 2023
- Trade date
- Nov 20, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $305.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bellon ChristineCIK 0001963878 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | Common Stock | MOption exerciseAcquired | +4,182 | $7.22 | +$30,194.04 | 86,584 | Direct | |
| Nov 20, 2023 | Common Stock | MOption exerciseAcquired | +5,818 | $7.22 | +$42,005.96 | 92,402 | Direct | |
| Nov 20, 2023 | Common Stock | SSaleDisposed | −5,000 | $30.00 | −$150,000 | 87,402 | Direct | |
| Nov 20, 2023 | Common Stock | SSaleDisposed | −5,000 | $31.00 | −$155,000 | 82,402 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | Common Stock | MOption exerciseDisposed | −4,182 | $0.00 | $0 | 9,492 | Direct | |
| Nov 20, 2023 | Common Stock | MOption exerciseDisposed | −5,818 | $0.00 | $0 | 10,918 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.